SCHEDULE 13G

Company

Protara Therapeutics, Inc.

Filed

October 31, 2014

Accession Number

0001144204-14-064444

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →